LP
RVMDW icon

LMR Partners’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

LMR Partners’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.5M Buy
5,066,598
+1,228,574
+32% +$6.65M 0.18% 121
2026
Q1 		$6.87M Buy
3,838,024
+686,319
+22% +$1.33M 0.02% 542
2025
Q4 		$2.96M Buy
3,151,705
+505,682
+19% +$285K 0.01% 718
2025
Q3 		$794K Hold
2,646,023
– – ﹤0.01% 1000
2025
Q2 		$695K Buy
2,646,023
+39,303
+2% +$5.83K 0.01% 873
2025
Q1 		$99.1K Buy
2,606,720
+11,475
+0.4% +$1.42K ﹤0.01% 1141
2024
Q4 		$467K Buy
+2,595,245
New +$767K ﹤0.01% 847
2024
Q3 		– Sell
-2,185,658
Closed -$266K – 1483
2024
Q2 		$223K Hold
2,185,658
– – ﹤0.01% 842
2024
Q1 		$399K Buy
+2,185,658
New +$442K ﹤0.01% 796

Other funds holding RVMDW

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

LMR Partners's RVMDW Position: Q2 2026 in Review

LMR Partners increased its Revolution Medicines Inc Warrant (RVMDW) stake by 32% in Q2 2026, buying an estimated $6.65M and bringing the position to 5,066,598 shares worth $47.5M. The position accounts for 0.18% of the portfolio, ranked #121.

LMR Partners first reported a position in RVMDW in Q1 2024 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • LMR Partners held 5,066,598 shares of Revolution Medicines Inc Warrant worth $47.5M as of Q2 2026.
  • LMR Partners bought 1,228,574 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $6.65M.
  • Revolution Medicines Inc Warrant made up 0.18% of LMR Partners's portfolio in Q2 2026, its #121 holding.
  • LMR Partners first reported a position in Revolution Medicines Inc Warrant in Q1 2024 and has held it in 9 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.